Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Grand House Mulia Tbk. (HOMI) vs Indofarma Tbk. (INAF)

Grand House Mulia Tbk.Trading
Indofarma Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Grand House Mulia Tbk. dan Indofarma Tbk.: Grand House Mulia Tbk. diperdagangkan di Rp232 (kapitalisasi pasar 384,3 M, volume 24 jam 3,49 jt), sedangkan Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M). Perbedaan utamanya: Grand House Mulia Tbk. dan Indofarma Tbk. berukuran mirip dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.

HOMIINAF
Kapitalisasi Pasar
384,3 M390,51 M
Volume
3,49 jt
Lot
34,89 rb
Perputaran
796,11 jt
Harga Rata-rata
228,18
Nilai Transaksi
796,11 jt
Harga Ekuilibrium Indikatif
232
Volume Ekuilibrium Indikatif
110

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

HOMI
Lihat detail
INAF
Lihat detail

Tentang Grand House Mulia Tbk.

PT Grand House Mulia, Tbk (“the Company”) was established in Republic of Indonesia based on the Notarial Deed No. 1 dated January 9, 2006 of Suryati Moerwibowo, S.H., The Company has commercially operated in April 2019.

Selengkapnya di halaman HOMI

Tentang Indofarma Tbk.

PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.

Selengkapnya di halaman INAF